Your browser doesn't support javascript.
loading
The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma.
Sellin, Mark; Berg, Stephanie; Hagen, Patrick; Zhang, Jiwang.
Affiliation
  • Sellin M; Department of Cancer Biology, Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Loyola University Chicago, USA.
  • Berg S; Loyola University Chicago, Department of Cancer Biology and Internal Medicine, Cardinal Bernardin Cancer Center, Stritch School of Medicine, Maywood, IL, USA. Electronic address: sberg2@luc.edu.
  • Hagen P; Department of Medicine, Division of Hematology/Oncology, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL USA.
  • Zhang J; Department of Cancer Biology, Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, USA.
Transl Oncol ; 22: 101448, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35660848
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Oncol Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Oncol Year: 2022 Type: Article Affiliation country: United States